| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |